Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain
Lucía Callén, Estefanía Moreno, Pedro Barroso‐Chinea, et al.
Journal of Biological Chemistry (2012) Vol. 287, Iss. 25, pp. 20851-20865
Open Access | Times Cited: 214

Showing 1-25 of 214 citing articles:

Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Sinemyiz Atalay, Iwona Jarocka-Karpowicz, Elżbieta Skrzydlewska
Antioxidants (2019) Vol. 9, Iss. 1, pp. 21-21
Open Access | Times Cited: 623
Cannabis, a complex plant: different compounds and different effects on individuals
Zerrin Atakan
Therapeutic Advances in Psychopharmacology (2012) Vol. 2, Iss. 6, pp. 241-254
Open Access | Times Cited: 484
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 414
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
Arnau Busquets‐Garcia, Jaideep S. Bains, Giovanni Marsicano
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 4-20
Open Access | Times Cited: 278
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation
Ismael Galve‐Roperh, Valerio Chiurchiù, Javier Díaz-Alonso, et al.
Progress in Lipid Research (2013) Vol. 52, Iss. 4, pp. 633-650
Closed Access | Times Cited: 259
G Protein–Coupled Receptor Heteromers
Ivone Gomes, Mohammed Akli Ayoub, Wakako Fujita, et al.
The Annual Review of Pharmacology and Toxicology (2015) Vol. 56, Iss. 1, pp. 403-425
Open Access | Times Cited: 247
CB2Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?
Amey Dhopeshwarkar, Ken Mackie
Molecular Pharmacology (2014) Vol. 86, Iss. 4, pp. 430-437
Open Access | Times Cited: 246
New Insights into Modes of GPCR Activation
Wenjing Wang, Yuhui Qiao, Zijian Li
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 4, pp. 367-386
Closed Access | Times Cited: 202
Brain cannabinoid receptor 2: expression, function and modulation
De‐Jie Chen, Ming Gao, Fenfei Gao, et al.
Acta Pharmacologica Sinica (2017) Vol. 38, Iss. 3, pp. 312-316
Open Access | Times Cited: 186
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors
Xavier Viñals, Estefanía Moreno, Laurence Lanfumey, et al.
PLoS Biology (2015) Vol. 13, Iss. 7, pp. e1002194-e1002194
Open Access | Times Cited: 182
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
Tommaso Cassano, Silvio Calcagnini, Lorenzo Pace, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 171
Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 24
CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice
Ester Aso, Salvador Juvés, Rafaël Maldonado, et al.
Journal of Alzheimer s Disease (2013) Vol. 35, Iss. 4, pp. 847-858
Open Access | Times Cited: 186
Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system
Keith A. Sharkey, Nissar A. Darmani, Linda A. Parker
European Journal of Pharmacology (2013) Vol. 722, pp. 134-146
Open Access | Times Cited: 182
Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
Eva Martínez‐Pinilla, Katia Varani, Irene Reyes‐Resina, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 169
An Update on Non-CB1, Non-CB2 Cannabinoid Related G-Protein-Coupled Receptors
Paula Morales, Patricia H. Reggio
Cannabis and Cannabinoid Research (2017) Vol. 2, Iss. 1, pp. 265-273
Open Access | Times Cited: 152
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
Gemma Navarro, Paula Morales, Carmen Rodríguez‐Cueto, et al.
Frontiers in Neuroscience (2016) Vol. 10
Open Access | Times Cited: 134
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
Sandeep Vasant More, Dong‐Kug Choi
Molecular Neurodegeneration (2015) Vol. 10, Iss. 1
Open Access | Times Cited: 133
Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer’s disease
Han Li, Yuzhi Liu, Danni Tian, et al.
European Journal of Medicinal Chemistry (2020) Vol. 192, pp. 112163-112163
Closed Access | Times Cited: 132
Cocaine Inhibits Dopamine D2 Receptor Signaling via Sigma-1-D2 Receptor Heteromers
Gemma Navarro, Estefanía Moreno, Jordi Bonaventura, et al.
PLoS ONE (2013) Vol. 8, Iss. 4, pp. e61245-e61245
Open Access | Times Cited: 127
Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self-Administration in Mice and Rats
Hai‐Ying Zhang, Guo-Hua Bi, Xia Li, et al.
Neuropsychopharmacology (2014) Vol. 40, Iss. 4, pp. 1037-1051
Open Access | Times Cited: 118
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling
Nariman Balenga, Eva Martínez‐Pinilla, Julia Kargl, et al.
British Journal of Pharmacology (2014) Vol. 171, Iss. 23, pp. 5387-5406
Open Access | Times Cited: 118
Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1–CB2 Heteroreceptor Complexes
Gemma Navarro, Katia Varani, Irene Reyes‐Resina, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 117
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 110
Emerging drugs of abuse: current perspectives on synthetic cannabinoids
Danièle Debruyne, Reynald Le Boisselier
Substance Abuse and Rehabilitation (2015), pp. 113-113
Open Access | Times Cited: 106
Page 1 - Next Page

Scroll to top